We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Blood Test Identifies Pancreatic Cancer in Patients With New-Onset Diabetes
Blood Test Identifies Pancreatic Cancer in Patients With New-Onset Diabetes
Bluestar Genomics’ cell-free DNA blood test identified pancreatic cancer in patients with newly diagnosed diabetes with sensitivity outcomes in the 50 percent range and specificity in the high 90s.